Miwon Specialty Chemical
At a glance
Miwon Specialty Chemical filed 60 disclosures in the last 12 months, including 8 insider, 3 5% holder and 3 buyback. The most recent key filing was on Oct 15: Plans to buy back 17,000 sh of treasury stock, Oct 15 to Jan 15.
Revenue for 2025 was ₩532B, up 4.5% on 2024. Operating margin was 12.3% against 11.5% a year earlier. Debt was 22% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩304B and operating profit of ₩56.4B.
The 2025 annual report lists 512 employees with an average tenure of 8.5 years and average pay of ₩71.8M, #547 of 1,829 listed companies by average pay. Its 7 directors and auditors were paid ₩178M each on average. It paid ₩3,200 per common share in cash dividends, against ₩2,500 a year earlier (+28%). 미원홀딩스주식회사 and related parties held 73.49% at year end.
From the 2025 annual report
Staff: 512 (437 men, 75 women), of whom 19 on fixed-term contracts. Total pay for the year: ₩37.4B. Directors and auditors: 7, paid ₩1.2B in total.
Dividends (common shares)
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash dividend per share | ₩3,200 | ₩2,500 | ₩2,100 |
| Payout ratio | 25.2% | 22.3% | 55.7% |
| Yield (as filed) | 2.20% | 1.70% | 1.50% |
| Total cash dividends | ₩15.4B | ₩12.2B | ₩10.4B |
Largest shareholder
미원홀딩스주식회사 holds 33.94%; with 36 related parties the group holds 73.49% of common shares at year end (from 73.71% at the start of the year).
Auditor: 한길회계법인 · opinion: Unqualified.
Source: 2025 annual business report (DART). How figures are combined
Financial summary
Key filings
Other filings
Links open the original filing on DART, in Korean.